98-22226. Ophthalmic and Topical Dosage Form New Animal Drugs; Ivermectin Topical Solution  

  • [Federal Register Volume 63, Number 160 (Wednesday, August 19, 1998)]
    [Rules and Regulations]
    [Pages 44384-44385]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-22226]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 524
    
    
    Ophthalmic and Topical Dosage Form New Animal Drugs; Ivermectin 
    Topical Solution
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
    drug regulations to reflect approval of an abbreviated new animal drug 
    application (ANADA) filed by Phoenix Scientific, Inc. The ANADA 
    provides for use of ivermectin topical (pour-on) solution on cattle for 
    the treatment and control of worms, grubs, lice, mites, and flies.
    
    EFFECTIVE DATE: August 19, 1998.
    
    FOR FURTHER INFORMATION CONTACT: Lonnie W. Luther, Center for 
    Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 
    Standish Pl., Rockville, MD 20855, 301-827-0209.
    
    SUPPLEMENTARY INFORMATION: Phoenix Scientific, Inc., 3915 South 48th 
    St. Terrace, P.O. Box 6457, St. Joseph, MO 64506-0457, filed ANADA 200-
    219 that provides for the topical use of PhoenectinTM Pour-
    On (5 milligrams of ivermectin per milliliter) for cattle for the 
    treatment and control of gastrointestinal roundworms (including 
    inhibited Ostertagia ostertagi), lungworms, grubs, horn flies, sucking 
    and biting lice, and sarcoptic mange mites.
        Phoenix Scientific, Inc.'s ANADA 200-219 ivermectin topical (pour-
    on) solution for cattle is approved as a generic copy of Merial, Ltd.'s 
    NADA 140-841 Ivomec (ivermectin) Pour-On for Cattle. The 
    ANADA is approved as of July 6, 1998, and 21 CFR 524.1193(b) and (d)(2) 
    are amended to reflect the approval. The basis of approval is discussed 
    in the freedom of information summary.
        In accordance with the freedom of information provisions of 21 CFR 
    part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness 
    data and information submitted to support approval of this application 
    may be seen in the Dockets Management Branch (HFA-305), Food and Drug 
    Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, 
    between 9 a.m. and 4 p.m., Monday through Friday.
        The agency has determined under 21 CFR 25.33(a)(1) that this action 
    is of a type that does not individually or cumulatively have a 
    significant effect on the human environment. Therefore, neither an 
    environmental assessment nor an environmental impact statement is 
    required.
    
    List of Subjects in 21 CFR Part 524
    
        Animal drugs.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner
    
    [[Page 44385]]
    
    of Food and Drugs and redelegated to the Center for Veterinary 
    Medicine, 21 CFR part 524 is amended as follows:
    
    PART 524--OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
    
        1. The authority citation for 21 CFR part 524 continues to read as 
    follows:
    
        Authority: 21 U.S.C. 360b.
        2. Section 524.1193 is amended by revising paragraphs (b) and 
    (d)(2) to read as follows:
    
    
    Sec. 524.1193   Ivermectin pour-on.
    
    * * * * *
         (b) Sponsors. (1) See No. 050604 in Sec. 510.600(c) of this 
    chapter for use as in paragraph (d) of this section.
        (2) See No. 059130 for use as in paragraphs (d)(1), (d)(2)(i), and 
    (d)(3) of this section.
    * * * * *
         (d) * * *
         (2) Indications for use. (i) For cattle: It is used for the 
    treatment and control of: Gastrointestinal roundworms (adults and 
    fourth-stage larvae) Ostertagia ostertagi (including inhibited stage), 
    Haemonchus placei, Trichostrongylus axei, T. colubriformis, Cooperia 
    spp., Oesophagostomum radiatum; (adults) O. venulosum, Strongyloides 
    papillosus, Trichuris spp.; lungworms (adults and fourth-stage larvae) 
    Dictyocaulus viviparus; cattle grubs (parasitic stages) Hypoderma 
    bovis, H. lineatum; mites Chorioptes bovis, Sarcoptes scabei var. 
    bovis; lice Linognathus vituli, Haematopinus eurysternus, Damalina 
    bovis, Solenoptes capillatus; horn flies Haematobia irritans.
        (ii) For cattle: It is also used to control infections of 
    gastrointestinal roundworms O. ostertagi, O. radiatum, H. placei, T. 
    axei, Cooperia punctata, and C. oncophora for 14 days after treatment.
    * * * * *
    
        Dated: August 3, 1998.
    Stephen F. Sundlof,
    Director, Center for Veterinary Medicine.
    [FR Doc. 98-22226 Filed 8-18-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
8/19/1998
Published:
08/19/1998
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
98-22226
Dates:
August 19, 1998.
Pages:
44384-44385 (2 pages)
PDF File:
98-22226.pdf
CFR: (1)
21 CFR 524.1193